S. Korean disease institute, Moderna agree to collaborate in SFTS mRNA vaccine development
Jul 20, 2022
South Korea's state-run National Institute of Infectious Diseases (NIID) said Wednesday it has reached an agreement with Moderna Inc., a US biotech company, to cooperate in the development of a messenger RNA (mRNA) vaccine candidate for severe fever and thrombocytopenia syndrome (SFTS). The institute said the deal, signed Monday, was its first joint project agreement with an overseas pharmaceuti...